62 related articles for article (PubMed ID: 18571382)
41. Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
Chao Q; Deng L; Shih H; Leoni LM; Genini D; Carson DA; Cottam HB
J Med Chem; 1999 Sep; 42(19):3860-73. PubMed ID: 10508435
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effects of erythropoietin in murine models of endotoxin shock.
Vollmar B; Eipel C; Menger MD
Crit Care Med; 2010 Jan; 38(1):340-1. PubMed ID: 20023499
[No Abstract] [Full Text] [Related]
43. Dansyl C-glucoside as a novel agent against endotoxic shock.
La Ferla B; Spinosa V; D'Orazio G; Palazzo M; Balsari A; Foppoli AA; Rumio C; Nicotra F
ChemMedChem; 2010 Oct; 5(10):1677-80. PubMed ID: 20726031
[No Abstract] [Full Text] [Related]
44. Effects of anti-inflammatory drugs in shock caused by injection of living E. coli cells.
Culp JR; Erdös EG; Hinshaw IB; Holmes DD
Proc Soc Exp Biol Med; 1971 May; 137(1):219-23. PubMed ID: 4932047
[No Abstract] [Full Text] [Related]
45. [Effect of clarithromycin on lipopolysaccharide-induced anorexia].
Hori S; Sato A; Kawamura M
Jpn J Antibiot; 2001 Dec; 54 Suppl C():19-21. PubMed ID: 12575411
[No Abstract] [Full Text] [Related]
46. Endotoxin cross tolerance: another inflammatory preconditioning stimulus?
Cain BS; Tung TC
Crit Care Med; 2000 Jun; 28(6):2164-5. PubMed ID: 10890698
[No Abstract] [Full Text] [Related]
47. [Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells].
Hamada K; Sakamoto M; Mikasa K; Teramoto M; Mori K; Tsujimoto M; Maeda K; Konishi M; Sawaki M; Narita N; Kita E
Jpn J Antibiot; 1997 Mar; 50 Suppl A():28-31. PubMed ID: 9597434
[No Abstract] [Full Text] [Related]
48. Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity.
Ivetić Tkalčević V; Cužić S; Kramarić MD; Parnham MJ; Eraković Haber V
Inflammation; 2012 Feb; 35(1):192-205. PubMed ID: 21336676
[TBL] [Abstract][Full Text] [Related]
49. Clarithromycin in adult-onset Still's disease: a study of 6 cases.
Saviola G; Benucci M; Abdi-Ali L; Baiardi P; Manfredi M; Bucci M; Cirino G
Rheumatol Int; 2010 Feb; 30(4):555-60. PubMed ID: 20033412
[TBL] [Abstract][Full Text] [Related]
50. LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.
Alexandre-Moreira MS; Takiya CM; de Arruda LB; Pascarelli B; Gomes RN; Castro Faria Neto HC; Lima LM; Barreiro EJ
Int Immunopharmacol; 2005 Mar; 5(3):485-94. PubMed ID: 15683845
[TBL] [Abstract][Full Text] [Related]
51. The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice.
Tkalcević VI; Bosnjak B; Pasalić I; Hrvacić B; Situm K; Kramarić MD; Glojnarić I; Eraković Haber V
Int J Antimicrob Agents; 2008 Aug; 32(2):195-6. PubMed ID: 18571382
[No Abstract] [Full Text] [Related]
52. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
[TBL] [Abstract][Full Text] [Related]
53. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Giamarellos-Bourboulis EJ; Baziaka F; Antonopoulou A; Koutoukas P; Kousoulas V; Sabracos L; Panagou C; Perrea D; Giamarellou H
Int J Antimicrob Agents; 2005 Feb; 25(2):168-72. PubMed ID: 15664488
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
55. Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Li X; Cui X; Li Y; Fitz Y; Hsu L; Eichacker PQ
Cytokine; 2006 Mar; 33(6):299-308. PubMed ID: 16720096
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
